Vycor Medical, Inc.
VYCO
$0.1179
$0.011310.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 436.40K | 455.20K | 390.90K | 406.30K | 337.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 436.40K | 455.20K | 390.90K | 406.30K | 337.00K |
| Cost of Revenue | 77.80K | 57.80K | 36.80K | 35.20K | 37.00K |
| Gross Profit | 358.50K | 397.40K | 354.10K | 371.10K | 300.00K |
| SG&A Expenses | 350.70K | 356.50K | 367.90K | 337.80K | 294.60K |
| Depreciation & Amortization | 14.90K | 14.90K | 14.90K | 14.90K | 14.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 449.20K | 435.90K | 426.00K | 390.10K | 346.50K |
| Operating Income | -12.80K | 19.30K | -35.10K | 16.20K | -9.50K |
| Income Before Tax | -38.50K | -6.70K | -59.80K | -10.00K | -30.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38.50K | -6.70K | -59.80K | -10.00K | -30.50K |
| Earnings from Discontinued Operations | 0.00 | -100.00 | 0.00 | 0.00 | -100.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.60K | -6.70K | -59.80K | -10.00K | -30.60K |
| EBIT | -12.80K | 19.30K | -35.10K | 16.20K | -9.50K |
| EBITDA | 3.30K | 36.20K | -19.40K | 31.90K | 6.10K |
| EPS Basic | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 33.37M | 33.38M | 32.90M | 32.63M | 32.63M |
| Average Diluted Shares Outstanding | 33.37M | 33.38M | 32.90M | 32.63M | 32.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |